Autoimmunity and Cancer

M. I. Sara Achenza, Carlo Selmi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The association between autoimmune diseases and cancer is to be considered one of the most well established and clinically challenging issues. Several mechanisms are shared in the pathogenesis of both autoimmune diseases and cancer, they are thus direct candidates as causative factors, but direct proof is lacking, as in the case of serum autoantibodies. Furthermore, accurate estimates of the risk of cancer in patients with newly diagnosed or long-standing autoimmune disease remain to be reported. The role of awareness bias and diagnosis latency, as well as of serum autoantibodies, epigenetics and genomic susceptibility, cannot be overlooked in this scenario. Finally, an indirect proof of associations is provided by the common autoimmune phenomena presenting as paraneoplastic. The present article will critically review the available evidence on the common mechanisms and epidemiology underlying the risk of cancer in patients with autoimmune disease.

Original languageEnglish (US)
Pages (from-to)29-40
Number of pages12
JournalAsian Pacific Journal of Cancer Prevention
Volume13
Issue numberSUPPL.1
DOIs
StatePublished - 2012

Fingerprint

Autoimmunity
Autoimmune Diseases
Autoantibodies
Neoplasms
Serum
Epigenomics
Epidemiology

Keywords

  • Autoimmunity
  • Cancer
  • Epidemiology
  • Genetic susceptibility

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Autoimmunity and Cancer. / Sara Achenza, M. I.; Selmi, Carlo.

In: Asian Pacific Journal of Cancer Prevention, Vol. 13, No. SUPPL.1, 2012, p. 29-40.

Research output: Contribution to journalArticle

Sara Achenza, M. I. ; Selmi, Carlo. / Autoimmunity and Cancer. In: Asian Pacific Journal of Cancer Prevention. 2012 ; Vol. 13, No. SUPPL.1. pp. 29-40.
@article{d9686da520b94ff2ae65a56963da1f15,
title = "Autoimmunity and Cancer",
abstract = "The association between autoimmune diseases and cancer is to be considered one of the most well established and clinically challenging issues. Several mechanisms are shared in the pathogenesis of both autoimmune diseases and cancer, they are thus direct candidates as causative factors, but direct proof is lacking, as in the case of serum autoantibodies. Furthermore, accurate estimates of the risk of cancer in patients with newly diagnosed or long-standing autoimmune disease remain to be reported. The role of awareness bias and diagnosis latency, as well as of serum autoantibodies, epigenetics and genomic susceptibility, cannot be overlooked in this scenario. Finally, an indirect proof of associations is provided by the common autoimmune phenomena presenting as paraneoplastic. The present article will critically review the available evidence on the common mechanisms and epidemiology underlying the risk of cancer in patients with autoimmune disease.",
keywords = "Autoimmunity, Cancer, Epidemiology, Genetic susceptibility",
author = "{Sara Achenza}, {M. I.} and Carlo Selmi",
year = "2012",
doi = "10.7314/APJCP.2012.13.KKSuppl.29",
language = "English (US)",
volume = "13",
pages = "29--40",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "SUPPL.1",

}

TY - JOUR

T1 - Autoimmunity and Cancer

AU - Sara Achenza, M. I.

AU - Selmi, Carlo

PY - 2012

Y1 - 2012

N2 - The association between autoimmune diseases and cancer is to be considered one of the most well established and clinically challenging issues. Several mechanisms are shared in the pathogenesis of both autoimmune diseases and cancer, they are thus direct candidates as causative factors, but direct proof is lacking, as in the case of serum autoantibodies. Furthermore, accurate estimates of the risk of cancer in patients with newly diagnosed or long-standing autoimmune disease remain to be reported. The role of awareness bias and diagnosis latency, as well as of serum autoantibodies, epigenetics and genomic susceptibility, cannot be overlooked in this scenario. Finally, an indirect proof of associations is provided by the common autoimmune phenomena presenting as paraneoplastic. The present article will critically review the available evidence on the common mechanisms and epidemiology underlying the risk of cancer in patients with autoimmune disease.

AB - The association between autoimmune diseases and cancer is to be considered one of the most well established and clinically challenging issues. Several mechanisms are shared in the pathogenesis of both autoimmune diseases and cancer, they are thus direct candidates as causative factors, but direct proof is lacking, as in the case of serum autoantibodies. Furthermore, accurate estimates of the risk of cancer in patients with newly diagnosed or long-standing autoimmune disease remain to be reported. The role of awareness bias and diagnosis latency, as well as of serum autoantibodies, epigenetics and genomic susceptibility, cannot be overlooked in this scenario. Finally, an indirect proof of associations is provided by the common autoimmune phenomena presenting as paraneoplastic. The present article will critically review the available evidence on the common mechanisms and epidemiology underlying the risk of cancer in patients with autoimmune disease.

KW - Autoimmunity

KW - Cancer

KW - Epidemiology

KW - Genetic susceptibility

UR - http://www.scopus.com/inward/record.url?scp=84874069533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874069533&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2012.13.KKSuppl.29

DO - 10.7314/APJCP.2012.13.KKSuppl.29

M3 - Article

VL - 13

SP - 29

EP - 40

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - SUPPL.1

ER -